Influence of Sodium Glucose Cotransporter 2 Inhibition on Physiological Adaptation to Endurance Exercise Training

Abstract Context The combination of two beneficial antidiabetes interventions, regular exercise and pharmaceuticals, is intuitively appealing. However, metformin, the most commonly prescribed diabetes medication, attenuates the favorable physiological adaptations to exercise; in turn, exercise may i...

Full description

Saved in:
Bibliographic Details
Published inThe journal of clinical endocrinology and metabolism Vol. 104; no. 6; pp. 1953 - 1966
Main Authors Newman, Alissa A, Grimm, Nathan C, Wilburn, Jessie R, Schoenberg, Hayden M, Trikha, S Raj J, Luckasen, Gary J, Biela, Laurie M, Melby, Christopher L, Bell, Christopher
Format Journal Article
LanguageEnglish
Published Washington, DC Endocrine Society 01.06.2019
Copyright Oxford University Press
Oxford University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Context The combination of two beneficial antidiabetes interventions, regular exercise and pharmaceuticals, is intuitively appealing. However, metformin, the most commonly prescribed diabetes medication, attenuates the favorable physiological adaptations to exercise; in turn, exercise may impede the action of metformin. Objective We sought to determine the influence of an alternative diabetes treatment, sodium glucose cotransporter 2 (SGLT2) inhibition, on the response to endurance exercise training. Design, Participants, and Intervention In a randomized, double-blind, repeated measures parallel design, 30 sedentary overweight and obese men and women were assigned to 12 weeks of supervised endurance exercise training, with daily ingestion of either a placebo or SGLT2 inhibitor (dapagliflozin: ≤10 mg/day). Outcome Measurements and Results Endurance exercise training favorably modified body mass, body composition (dual-energy x-ray absorptiometry), peak oxygen uptake (graded exercise with indirect calorimetry), responses to standardized submaximal exercise (indirect calorimetry, heart rate, and blood lactate), and skeletal muscle (vastus lateralis) citrate synthase activity (main effects of exercise training, all P < 0.05); SGLT2 inhibition did not influence any of these physiological adaptations (exercise training × treatment interaction, all P > 0.05). However, after endurance exercise training, fasting blood glucose was greater with SGLT2 inhibition, and increased insulin sensitivity (oral glucose tolerance test/Matsuda index) was abrogated with SGLT2 inhibition (exercise training × treatment interaction, P < 0.01). Conclusion The efficacy of combining two beneficial antidiabetes interventions, regular endurance exercise and SGLT2 inhibition, was not supported. SGLT2 inhibition blunted endurance exercise training–induced improvements in insulin sensitivity, independent of effects on aerobic fitness or body composition. Sodium glucose cotransporter 2 inhibition attenuates some of the favorable physiological adaptations to 12 weeks of endurance exercise training in previously sedentary overweight and obese adults.
ISSN:0021-972X
1945-7197
DOI:10.1210/jc.2018-01741